Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias. Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ...

Autoimmune hemolytic anemia (AIHA) is a rare but clinically significant disorder in which the immune system mistakenly produces autoantibodies against red blood cells, leading to accelerated ...

Cold agglutinin disease is a condition that causes low red blood cell (RBC) counts. Symptoms can include fatigue, weakness, or shortness of breath. Cold agglutinin disease is a type of autoimmune ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune ...

Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia — a condition in which you have inadequate red blood cells due to premature destruction of those cells by your own immune ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments. Autoimmune complications “occur very commonly for people with CLL,” which is important for ...

Although the exact incidence of IMHA in dogs is unknown, it’s considered one of the most common autoimmune conditions faced ...

Immune thrombocytopenia (ITP) is the second indication for which gamgertamig has received Orphan Drug Designation (ODD), following a first ODD for autoimmune hemolytic anemia (AIHA) Dosing is complete ...